Researchers have identified a new mechanism by which viruses that live in the human gut can outmanoeuvre the bacteria they infect, a finding that could eventually support efforts to combat antibiotic-resistant superbugs. The discovery, reported by Euronews.com and detailed in a study published in the scientific journal Nature, centres on how these viruses, known as bacteriophages or phages, adapt to hostile bacterial defences.
According to the reporting, the gut viruses possess specific genetic elements that allow them to hedge their bets against bacterial immune systems. This "bet-hedging" strategy means that within a single population of phages, some individuals carry genetic variations that may be ineffective under normal conditions but prove advantageous when a bacterium deploys its defence mechanisms. This pre-emptive variation increases the odds that at least some phages will survive and successfully infect the bacteria, even when facing a robust immune response.
The significance of this evolutionary trick lies in its potential application to phage therapy, an experimental treatment that uses viruses to kill harmful bacteria. As antibiotic resistance grows, phages are increasingly viewed as a viable alternative or supplement to traditional drugs. Understanding how phages naturally evolve to overcome bacterial defences could help scientists engineer more effective therapeutic phages for clinical use.
The research adds a new layer of understanding to the ongoing arms race between viruses and bacteria in the gut microbiome. While the work is at a fundamental research stage, it points toward a future where phage-based treatments could be tailored to exploit these genetic vulnerabilities in superbugs. The next step for scientists will be to translate these insights into practical strategies for developing phage therapies that can be deployed against resistant infections in humans.
